FDA 483 - Temple Creek Dairy, Inc. - December 09, 2021

An FDA inspection of Temple Creek Dairy, Inc. in Escalon, CA, revealed significant issues related to animal drug administration and record-keeping. Observations included the extralabel use of an approved drug resulting in violative residues in a cow sold for human consumption, incomplete medication treatment records, and failure to adhere to a veterinarian's prescription for drug frequency or duration. These findings highlight serious concerns regarding food safety and proper veterinary drug management at the dairy.